674 related articles for article (PubMed ID: 18096469)
1. Other immune thrombocytopenias.
Liebman H
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
[TBL] [Abstract][Full Text] [Related]
2. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias.
Stasi R
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S15-25. PubMed ID: 19245929
[TBL] [Abstract][Full Text] [Related]
4. Infectious causes of chronic immune thrombocytopenia.
Stasi R; Willis F; Shannon MS; Gordon-Smith EC
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1275-97. PubMed ID: 19932434
[TBL] [Abstract][Full Text] [Related]
5. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
Numeroso F; Baroni MC; Delsignore R
Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
7. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-associated immune thrombocytopenia.
Franchini M; Veneri D
Platelets; 2006 Mar; 17(2):71-7. PubMed ID: 16421007
[TBL] [Abstract][Full Text] [Related]
9. Does H. Pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases?
Gasbarrini A; Franceschi F
Am J Gastroenterol; 2005 Jun; 100(6):1271-3. PubMed ID: 15929756
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.
Samuel H; Nardi M; Karpatkin M; Hart D; Belmont M; Karpatkin S
Br J Haematol; 1999 Jun; 105(4):1086-91. PubMed ID: 10554825
[TBL] [Abstract][Full Text] [Related]
12. Immune thrombocytopenia in patients with connective tissue disorders and the antiphospholipid antibody syndrome.
Arkfeld DG; Weitz IC
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1239-49. PubMed ID: 19932431
[TBL] [Abstract][Full Text] [Related]
13. Pathobiology of secondary immune thrombocytopenia.
Cines DB; Liebman H; Stasi R
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S2-14. PubMed ID: 19245930
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates in patients with elevated platelet-associated immunoglobulins.
Szal M; Blumberg N
Ann Clin Lab Sci; 1988; 18(1):24-33. PubMed ID: 3355094
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of thrombopoietin in the diagnosis of peripheral thrombocytopenias.
Español I; Hernández A; Muñiz-Diaz E; Ayats R; Pujol-Moix N
Haematologica; 1999 Jul; 84(7):608-13. PubMed ID: 10406902
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
Pockros PJ; Duchini A; McMillan R; Nyberg LM; McHutchison J; Viernes E
Am J Gastroenterol; 2002 Aug; 97(8):2040-5. PubMed ID: 12190174
[TBL] [Abstract][Full Text] [Related]
17. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment.
Veneri D; De Matteis G; Solero P; Federici F; Zanuso C; Guizzardi E; Arena S; Gaio M; Pontiero P; Ricetti MM; Franchini M
Platelets; 2005 Aug; 16(5):307-11. PubMed ID: 16011982
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the underlying causes of the immune thrombocytopenia: Ten years experience.
Dal MS; Karakus A; Dal T; Aydin BB; Hattapoglu E; Ekmen MO; Ulas T; Ayyildiz O
J Pak Med Assoc; 2017 Jul; 67(7):1004-1008. PubMed ID: 28770876
[TBL] [Abstract][Full Text] [Related]
19. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
20. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
Rostami N; Keshtkar-Jahromi M; Rahnavardi M; Keshtkar-Jahromi M; Esfahani FS
Am J Hematol; 2008 May; 83(5):376-81. PubMed ID: 18183613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
